Zantac® Cancer Attorneys
Zantac® and similar generic versions of this over-the-counter drug are being recalled worldwide. Millions of people use either Zantac® or generic ranitidine. Unfortunately, these drugs contain N-nitrosodimethylamine (NDMA) which has been found to cause cancer.
Evidence shows that pharmaceutical companies have known that cancer is linked to Zantac®. However, they have hidden this information from the public–ultimately putting profits before safety.
Getting Compensated for Zantac®-Related Cancer
Zantac® and the generic version Ranitidine decreases stomach acid and was approved by the FDA in 1983. The over-the-counter version became available to customers in stores in 1996 and by 2018 was going strong as one of the top-selling antacids in the country.
The most common uses for Zantac® and the generic version was to treat gastrointestinal discomfort such as:
- Indigestion and heartburn
- Peptic ulcers
- Gastroesophageal reflux disease (acid reflux)
- Zollinger-Ellison syndrome
Patients found relief to these common gastrointestinal digestive issues. Yet, it was recently discovered there are high levels of the carcinogen NDMA and both Zantac®, and ranitidine was pulled off the shelves and no longer for sale.
Thus, you may be entitled to financial compensation if you have been diagnosed with cancer in the last three months after taking Zantac®. Common cancers from Zantac® (or generic ranitidine over-the-counter medications) include:
If you or someone you know meets the above description, you can get a free consultation from the legal team at Ron Bell Injury Lawyers. You have nothing to lose when we tackle your case, as you will not pay anything until you receive your settlement.
The Dangers of Zantac® and the Link between Cancer and NDMA
The chemical NDMA is often produced by the industrial process or a byproduct of chlorination of drinking and wastewater and even used to make rocket fuel. Once it was discovered, though, that rocket fuel plants were contaminating the air, water, and soil, the use of NDMA was stopped.
Further research was done and found a common link between cancer and NDMA. Recently, NDMA was discovered to be a natural byproduct of the same ingredients used to produce Zantac®. The drug produces NDMA within itself when exposed to heat, producing NDMA. Exposure to heat can happen during transport, and a chemical reaction can take place inside the body after taking the medication.
Valisure Beats the FDA to the Punch in Exposing the Dangers of Zantac®
Since the FDA allowed Zantac® and generic ranitidine to be available for decades, it seems that they prioritized their own financial gains over the best interest of the public by failing to warn consumers of the risks associated with Zantac®. Fortunately, there was one small pharmacy by the name of Valisure that stood up to sound the alarm.
The people at Valisure did their own tests on Zantac® and were shocked by the results. The pharmacy was then quick to take action. Once Valisure discovered Zantac® and other drugs that contained ranitidine had NDMA, it contacted the FDA and filed a petition to have Zantac® removed from the sales market.
After the petition was filed, it became increasingly evident that the risks should have or were already known. After all, scientists had noted thatranitidine could react with nitrates in the body and create NDMA as early as 1983.
There have been numerous tests performed in the years since, both on rats and humans. These revealed that NDMA causes liver tumors in rats and that NDMA is present in human urine after taking Zantac®.
These findings were never brought to the public, nor were there enough testing to research how the NDMA risks could affect humans long term. Even with the dangers present, the producers of Zantac® failed to warn the consumers, ultimately putting many at risk of cancer.
Considering that Zantac® and its generic alternative have higher NDMA traces than what was actually FDA-approved, many retail stores and pharmacies have pulled the medications from their shelves.
Who is Legally Responsible?
Over the last 30 years, several pharmaceutical companies took ownership of the Zantac® brand. Starting in 2006, the drug was manufactured and distributed by Boehringer, and from 2017 on, Sanofi took over. During these years, there was plenty of evidence of the dangers of ranitidine which both companies failed to present to the public. Not even a simple warning label was provided.
Had the warnings of ranitidine come earlier, the financial implications to the companies would still have been devastating. But, as we have come to realize, many adult and children’s lives would not be in jeopardy today.
Now that the dangers and risks are public knowledge, class-action suits have been filed to hold pharmaceutical companies accountable for their negligence while manufacturing and distributing this harmful drug.
Ron Bell Personal Injury Lawyers Can Help You Hold the Pharmaceutical Companies Responsible
Since the dangers and risks of Zantac® and ranitidine have been exposed, doctors are advising patients of alternative acid reflux and digestive drug alternatives. If you have taken Zantac®, you should consult your doctor to see if there is an alternative medication for your gastrointestinal discomfort.
If you are one of the many patients that took Zantac® or ranitidine and developed cancer, you may be entitled to compensation. You should contact Ron Bell Injury Lawyers regarding the possibility of filing a Zantac® lawsuit. Our attorneys understand how important it is that these companies are held responsible for their negligence.
Why is Ron Bell Your Best Choice for Your Zantac® Lawsuit?
Big powerful pharmaceutical companies like Boehringer and Sanofi can be intimidating, but Ron Bell Injury Lawyers is willing to fight for you so you don’t have to fight on your own. You need a law firm with extensive knowledge, resources, and experience to take these companies head-on – and that’s us. Our legal team has the expertise to take on bad drug cases at both state and district levels to help you get the compensation you deserve.
If you are involved in a Zantac® cancer lawsuit, your compensation may include:
- Medical bills
- Lost wages
- Pain and suffering
- Loss of life
- Punitive damages
Once you have partnered with us to take on your Zantac® cancer lawsuit, we will:
- Meet with you and run a thorough investigation to learn how Zantac® has affected you and your family both financially and medically
- Contact pharmacology and other medical experts that can determine who is responsible and accountable for your injuries
- Gather all supporting evidence for your case including medical records
- Fight to get you the top compensation for your losses
Because there is a statute of limitations deadline, you should contact a lawyer as soon as possible. You don’t want to miss out on the compensation that could be owed to you!
We understand that you may feel violated because you had confidence in the FDA, put trust in the drug manufacturers, and believed you were taking a safe drug. You deserve justice. If you or someone you know has taken Zantac® or a generic form of ranitidine and was diagnosed with cancer, we want to help you by offering a risk-free consultation with no out-of-pocket expenses.
Contact the Zantac® cancer lawyers Ron Bell Injury Lawyers and let us help you determine if you are eligible for a Zantac® lawsuit and settlement. Call our Albuquerque office today at 505-898-2355 to get started.